Advertisement
Screener

Oyster Point Pharma, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities

Oyster Point Pharma, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities

Oyster Point Pharma, Inc. reported Interest Paid, Excluding Capitalized Interest, Operating Activities of $6.63 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:InterestPaidNet · last filed 2022-11-10

  • Oyster Point Pharma, Inc. interest paid, excluding capitalized interest, operating activities for the quarter ending 2022-09-30 was $2.44M, a 296.27% increase year-over-year.
  • Oyster Point Pharma, Inc. interest paid, excluding capitalized interest, operating activities for the quarter ending 2022-06-30 was $2.12M.
  • Oyster Point Pharma, Inc. interest paid, excluding capitalized interest, operating activities for the quarter ending 2022-03-31 was $2.07M.
  • Oyster Point Pharma, Inc. interest paid, excluding capitalized interest, operating activities for the quarter ending 2021-12-31 was $1.74M.
  • Oyster Point Pharma, Inc. interest paid, excluding capitalized interest, operating activities for fiscal 2021 was $2.35M.
  • Oyster Point Pharma, Inc. interest paid, excluding capitalized interest, operating activities for fiscal 2020 was $0.00.
Period endInterest Paid, Excluding Capitalized Interest, Operating Activities 3 monthInterest Paid, Excluding Capitalized Interest, Operating Activities 6 monthInterest Paid, Excluding Capitalized Interest, Operating Activities 9 monthInterest Paid, Excluding Capitalized Interest, Operating Activities 12 month
2022-09-30$2.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$4.57M
derived: sum of 2 quarters · filed 2022-11-10
$6.63M
10-Q · filed 2022-11-10
$8.37M
derived: sum of 4 quarters · filed 2022-11-10
2022-06-30$2.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$4.19M
10-Q · filed 2022-08-11
$5.92M
derived: sum of 3 quarters · filed 2022-08-11
$6.54M
derived: sum of 4 quarters · filed 2022-11-10
2022-03-31$2.07M
10-Q · filed 2022-05-05
$3.80M
derived: sum of 2 quarters · filed 2022-05-05
$4.42M
derived: sum of 3 quarters · filed 2022-11-10
$4.42M
derived: sum of 4 quarters · filed 2022-11-10
2021-12-31$1.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$2.35M
derived: sum of 2 quarters · filed 2022-11-10
$2.35M
derived: sum of 3 quarters · filed 2022-11-10
$2.35M
10-K · filed 2022-02-24
2021-09-30$617.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$617.00K
derived: sum of 2 quarters · filed 2022-11-10
$617.00K
10-Q · filed 2022-11-10
$617.00K
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$0.00
10-Q · filed 2022-08-11
$0.00
derived: sum of 3 quarters · filed 2022-08-11
2021-03-31$0.00
10-Q · filed 2022-05-05
$0.00
derived: sum of 2 quarters · filed 2022-05-05
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$0.00
10-K · filed 2022-02-24
2020-09-30$0.00
10-Q · filed 2021-11-04